Real-world study of durvalumab and chemotherapy in Indian patients with advanced biliary tract cancers

被引：0
|
作者：
Muddu, V. [1 ]
Shah, A. [2 ]
Raj, A. [3 ]
Bahl, A. [4 ]
Thirumalairaj, R. [5 ]
Ghosh, J. [6 ]
Ostwal, V. [2 ]
Rajappa, S. [7 ]
Vora, A. [8 ]
Lavingia, V. [9 ]
Sharma, A. [10 ]
Khan, A. [1 ]
Rohatgi, N. [4 ]
Mahajan, M. [11 ]
Chandrakanth, M. [6 ]
Ramaswamy, A. [12 ]
机构：
[1] AIG Hosp, Hyderabad, India
[2] Tata Mem Hosp, Tata Mem Ctr, Mumbai, Maharashtra, India
[3] Sarvodaya Hosp, Faridabad, India
[4] Fortis Canc Inst, Gurgaon, India
[5] Apollo Canc Ctr, Chennai, Tamil Nadu, India
[6] Tata Med Ctr, Kolkata, India
[7] Basavatarakam Indo Amer Canc Hosp, Hyderabad, India
[8] HOPE Oncol Care Clin, New Delhi, India
[9] HCG Canc Ctr, Ahmadabad, Gujarat, India
[10] All India Inst Med Sci, New Delhi, India
[11] Pacific Med Coll Hosp, Udaipur, Rajasthan, India
[12] Tata Mem Hosp, Mumbai, Maharashtra, India
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.04.265
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-209
引用
收藏
页码：S90 / S90
页数：1
相关论文
共 50 条
  • [11] Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data
    Rimini, M.
    Fornaro, L.
    Lonardi, S.
    Niger, M.
    Lucchetti, J.
    Giordano, G.
    Scartozzi, M.
    Tamburini, E.
    Rapposelli, I.
    Martinelli, E.
    Garajova, I.
    Schirripa, M.
    Rimassa, L.
    Antonuzzo, L.
    Gardini, A. Casadei
    ANNALS OF ONCOLOGY, 2023, 34 : S28 - S28
  • [12] Single-center real-world experience from 18 consecutive cases treated with durvalumab in combination with chemotherapy for advanced biliary tract cancer
    Zhang, D.
    Heinemann, V.
    Haas, M.
    Heinrich, K.
    Weiss, L.
    Boukovala, M.
    Probst, V.
    Anna, R.
    Beyer, G.
    von Bergwelt-Baldion, M.
    Westphalen, B.
    Boeck, S.
    Dorman, K.
    ANNALS OF ONCOLOGY, 2023, 34 : S42 - S42
  • [13] A phase II study of tremelimumab, durvalumab, and bevacizumab in advanced biliary tract cancers
    Coffman, Kelley Lauren
    Xie, Changqing
    Hrones, Donna M.
    Monge, B. M. Cecilia
    Kleiner, David E.
    Steinberg, Seth M.
    Redd, Bernadette
    Wood, Brad J.
    Kassin, Michael
    Levy, Elliot
    Benmebarek, Mohamed-Reda
    Greten, Tim F.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [14] Efficacy, safety and differential outcomes of immune-chemotherapy with gemcitabine, cisplatin and durvalumab in patients with biliary tract cancers: A multicenter real world cohort
    Mitzlaff, Katharina
    Kirstein, Martha M.
    Mueller, Christian
    Venerito, Marino
    Olkus, Alexander
    Dill, Michael T.
    Weinmann, Arndt
    Kocheise, Lorenz
    Busch, Alina
    Schulze, Kornelius
    Allo, Gabriel
    Waldschmidt, Dirk-Thomas
    Barsch, Maryam
    Bengsch, Bertram
    Quante, Michael
    Gonzalez-Carmona, Maria A.
    Himmelsbach, Vera
    Finkelmeier, Fabian
    Kloeckner, Roman
    Schirmacher, Peter
    Marquardt, Jens U.
    Zimpel, Carolin
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2024, 12 (09) : 1230 - 1242
  • [15] Real-world outcomes among patients with advanced or metastatic biliary tract cancers initiating second-line treatment
    Cosgrove, David P.
    Reese, Emily S.
    Fulcher, Nicole M.
    Bobiak, Sarah S.
    Lamy, Francois-Xavier
    Allignol, Arthur
    Boyd, Marley
    Mahmoudpour, Seyed H.
    CANCER MEDICINE, 2023, 12 (04): : 4195 - 4205
  • [16] Real world experience with gemcitabine, cisplatin and durvalumab for first line treatment of advanced biliary tract cancers in Australia - Preliminary results
    Symons, Rebecca
    Lau, David
    Freckelton, Julia
    Tebbutt, Niall
    Iatropoulos, Georgios
    Dean, Andrew
    Robinson, Maclain
    Singhal, Nimit
    Goldstein, David
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 : 197 - 198
  • [17] Chemotherapy for biliary tract cancer: real-world experience in a single institute
    Maeda, Osamu
    Ebata, Tomoki
    Shimokata, Tomoya
    Matsuoka, Ayumu
    Inada-Inoue, Megumi
    Morita, Sachi
    Takano, Yuko
    Urakawa, Hiroshi
    Miyai, Yuki
    Sugishita, Mihoko
    Mitsuma, Ayako
    Ando, Masahiko
    Mizuno, Takashi
    Nagino, Masato
    Ando, Yuichi
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2020, 82 (04): : 725 - 733
  • [18] Real-World Evidence on Palliative Gemcitabine and Oxaliplatin (GemOx) Combination Chemotherapy in Advanced Biliary Tract Cancer
    Lagenfelt, Hanna
    Blomstrand, Hakon
    Elander, Nils O.
    CANCERS, 2021, 13 (14)
  • [19] Exploring the impact of durvalumab on biliary tract cancer: insights from real-world clinical data
    Reimann, Patrick
    Mavroeidi, Ilektra-Antonia
    Burghofer, Jonathan
    Taghizadeh, Hossein
    Webersinke, Gerald
    Kasper, Stefan
    Schreil, Georg
    Morariu, Darius
    Reichinger, Andreas
    Baba, Hideo Andreas
    Kirchweger, Patrick
    Schuler, Martin
    Djanani, Angela
    Prager, Gerald W.
    Rumpold, Holger
    Benda, Magdalena
    Schneider, Eva-Maria
    Mink, Sylvia
    Winder, Thomas
    Doleschal, Bernhard
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (12)
  • [20] REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN UNRESECTABLE ADVANCED AND METASTATIC BILIARY TRACT CANCERS (BTC): A LITERATURE REVIEW
    Peirce, V
    Qin, L.
    Geldman, E.
    Dadzie, R.
    Prince, S.
    Johal, S.
    VALUE IN HEALTH, 2023, 26 (06) : S36 - S37
12345